{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:49:23Z","timestamp":1774507763277,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"am","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100030820","name":"Drug Discovery Center, College of Pharmacy, Health Science Center, University of Tennessee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS120327"],"award-info":[{"award-number":["R01NS120327"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG058467"],"award-info":[{"award-number":["R01AG058467"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61NS124923"],"award-info":[{"award-number":["R61NS124923"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG072703"],"award-info":[{"award-number":["RF1AG072703"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD016226"],"award-info":[{"award-number":["1S10OD016226"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bmc.2024.118021","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T16:07:46Z","timestamp":1732637266000},"page":"118021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Discovery of a potent and selective TRPC3 antagonist with neuroprotective effects"],"prefix":"10.1016","volume":"117","author":[{"given":"Jiaxing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay K.","family":"Boda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunseo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyur","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duane D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Meibohm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyang","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca-Fang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongzhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.118021_b0005","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0092-8674(02)00670-0","article-title":"The TRP channels, a remarkably functional family","volume":"108","author":"Montell","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2024.118021_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells9091983","article-title":"Transient receptor potential canonical (TRPC) channels: then and now","volume":"9","author":"Chen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2024.118021_b0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/cells3020455","article-title":"Physiological function and characterization of TRPCs in neurons","volume":"3","author":"Sun","year":"2014","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2024.118021_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/cells7070083","article-title":"TRPC3 as a target of novel therapeutic interventions","volume":"7","author":"Tiapko","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2024.118021_b0025","article-title":"Modulation and regulation of canonical transient receptor potential 3 (TRPC3)","volume":"12","author":"Cole","year":"2023","journal-title":"Channels Cells"},{"key":"10.1016\/j.bmc.2024.118021_b0030","doi-asserted-by":"crossref","first-page":"33487","DOI":"10.1074\/jbc.M605536200","article-title":"Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling","volume":"281","author":"Bush","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.118021_b0035","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1038\/sj.emboj.7601417","article-title":"TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy","volume":"25","author":"Onohara","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.bmc.2024.118021_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/srep39383","article-title":"TRPC3-GEF-H1 axis mediates pressure overload-induced cardiac fibrosis","volume":"6","author":"Numaga-Tomita","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2024.118021_b0045","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.112.121830","article-title":"Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation","volume":"126","author":"Harada","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bmc.2024.118021_b0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12576-016-0480-1","article-title":"Transient receptor potential cation 3 channel regulates melanoma proliferation and migration","volume":"67","author":"Oda","year":"2017","journal-title":"J Physiol Sci"},{"key":"10.1016\/j.bmc.2024.118021_b0055","article-title":"Involvement of TRPC channels in lung cancer cell differentiation and the correlation analysis in human non-small cell lung cancer","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2024.118021_b0060","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1038\/oncsis.2013.40","article-title":"The histone variant MacroH2A regulates Ca(2+) influx through TRPC3 and TRPC6 channels","volume":"2","author":"Kim","year":"2013","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bmc.2024.118021_b0065","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1038\/s41388-022-02411-w","article-title":"PLAA suppresses ovarian cancer metastasis via METTL3-mediated m(6)A modification of TRPC3 mRNA","volume":"41","author":"Shen","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2024.118021_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23041967","article-title":"Lysophosphatidic acid promotes the expansion of cancer stem cells via TRPC3 channels in triple-negative breast cancer","volume":"23","author":"Hirata","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2024.118021_b0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2021.07.038","article-title":"TRPC3 promotes tumorigenesis of gastric cancer via the CNB2\/GSK3beta\/NFATc2 signaling pathway","volume":"519","author":"Lin","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmc.2024.118021_b0080","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/STROKEAHA.113.679332","article-title":"Transient receptor potential canonical 3 inhibitor Pyr3 improves outcomes and attenuates astrogliosis after intracerebral hemorrhage in mice","volume":"44","author":"Munakata","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.bmc.2024.118021_b0085","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10571-013-9931-x","article-title":"Endothelial transient receptor potential conical channel (TRPC)-3 activation induces vasogenic edema formation in the rat piriform cortex following status epilepticus","volume":"33","author":"Ryu","year":"2013","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.bmc.2024.118021_b0090","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10571-018-0586-5","article-title":"Canonical transient receptor potential channel 3 contributes to febrile seizure inducing neuronal cell death and neuroinflammation","volume":"38","author":"Sun","year":"2018","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.bmc.2024.118021_b0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainres.2017.07.020","article-title":"TRPC3- and ET(B) receptor-mediated PI3K\/AKT activation induces vasogenic edema formation following status epilepticus","volume":"1672","author":"Kim","year":"2017","journal-title":"Brain Res"},{"key":"10.1016\/j.bmc.2024.118021_b0100","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/epi.17190","article-title":"Inhibition of TRPC3 channels by a novel pyrazole compound confers antiseizure effects","volume":"63","author":"Nagib","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.bmc.2024.118021_b0105","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1073\/pnas.0810599106","article-title":"A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice","volume":"106","author":"Becker","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2024.118021_b0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbr.2014.12.018","article-title":"TRPC3 channels critically regulate hippocampal excitability and contextual fear memory","volume":"281","author":"Neuner","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bmc.2024.118021_b0115","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbr.2016.06.002","article-title":"Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer's disease mouse models","volume":"322","author":"Neuner","year":"2017","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bmc.2024.118021_b0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/16711","article-title":"Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol","volume":"397","author":"Hofmann","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.118021_b0125","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature03477","article-title":"Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor","volume":"434","author":"Li","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.118021_b0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nn1870","article-title":"TRPC channels promote cerebellar granule neuron survival","volume":"10","author":"Jia","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bmc.2024.118021_b0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molimm.2014.10.018","article-title":"Activation of calcium-sensing receptor increases TRPC3\/6 expression in T lymphocyte in sepsis","volume":"64","author":"Wu","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.bmc.2024.118021_b0140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijbs.10754","article-title":"Brain-derived neurotrophic factor regulates TRPC3\/6 channels and protects against myocardial infarction in rodents","volume":"11","author":"Hang","year":"2015","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.bmc.2024.118021_b0145","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.kint.2016.12.033","article-title":"TRPC6 and kidney disease: sclerosing more than just glomeruli?","volume":"91","author":"Schlondorff","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.bmc.2024.118021_b0150","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1128\/MCB.25.16.6980-6989.2005","article-title":"Increased vascular smooth muscle contractility in TRPC6-\/- mice","volume":"25","author":"Dietrich","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bmc.2024.118021_b0155","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1242\/jcs.026906","article-title":"TRPC6 channels promote dendritic growth via the CaMKIV-CREB pathway","volume":"121","author":"Tai","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bmc.2024.118021_b0160","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nn.2127","article-title":"Critical role of TRPC6 channels in the formation of excitatory synapses","volume":"11","author":"Zhou","year":"2008","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bmc.2024.118021_b0165","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuroscience.2015.08.054","article-title":"The role of TRPC6 in seizure susceptibility and seizure-related neuronal damage in the rat dentate gyrus","volume":"307","author":"Kim","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bmc.2024.118021_b0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10571-012-9875-6","article-title":"The reverse roles of transient receptor potential canonical channel-3 and -6 in neuronal death following pilocarpine-induced status epilepticus","volume":"33","author":"Kim","year":"2013","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.bmc.2024.118021_b0175","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s12035-014-8871-x","article-title":"Upregulation and diverse roles of TRPC3 and TRPC6 in synaptic reorganization of the mossy fiber pathway in temporal lobe epilepsy","volume":"52","author":"Zeng","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.bmc.2024.118021_b0180","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1073\/pnas.0808793106","article-title":"Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound","volume":"106","author":"Kiyonaka","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2024.118021_b0185","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/acsmedchemlett.0c00571","article-title":"Discovery of a highly selective and potent TRPC3 inhibitor with high metabolic stability and low toxicity","volume":"12","author":"Zhang","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.118021_b0190","doi-asserted-by":"crossref","first-page":"32540","DOI":"10.1074\/jbc.M602496200","article-title":"Homer 1 mediates store- and inositol 1,4,5-trisphosphate receptor-dependent translocation and retrieval of TRPC3 to the plasma membrane","volume":"281","author":"Kim","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.118021_b0195","doi-asserted-by":"crossref","DOI":"10.1038\/srep37001","article-title":"TRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling","volume":"6","author":"Kitajima","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2024.118021_b0200","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1113\/jphysiol.2013.251249","article-title":"Molecular determinants for cardiovascular TRPC6 channel regulation by Ca2+\/calmodulin-dependent kinase II","volume":"591","author":"Shi","year":"2013","journal-title":"J Physiol"},{"key":"10.1016\/j.bmc.2024.118021_b0205","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.molcel.2007.01.021","article-title":"Integration of phosphoinositide- and calmodulin-mediated regulation of TRPC6","volume":"25","author":"Kwon","year":"2007","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.bmc.2024.118021_b0210","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bpj.2012.11.2513","article-title":"Characterization of small molecule TRPC3 and TRPC6 agonist and antagonists","volume":"104","author":"Xu","year":"2013","journal-title":"Biophys J"},{"key":"10.1016\/j.bmc.2024.118021_b0215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12990-015-0021-6","article-title":"In vivo patch-clamp analysis of the antinociceptive actions of TRPA1 activation in the spinal dorsal horn","volume":"11","author":"Yamanaka","year":"2015","journal-title":"Mol Pain"},{"key":"10.1016\/j.bmc.2024.118021_b0220","first-page":"3","article-title":"A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain","volume":"2013","author":"Nativi","year":"2005","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2024.118021_b0225","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/sj.bjp.0703918","article-title":"Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)","volume":"132","author":"McIntyre","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2024.118021_b0230","article-title":"Molecular mechanisms underlying menthol binding and activation of TRPM8 ion channel","volume":"11","author":"Xu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2024.118021_b0235","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0705652","article-title":"Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay","volume":"141","author":"Behrendt","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2024.118021_b0240","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41422-018-0038-2","article-title":"Structure of the receptor-activated human TRPC6 and TRPC3 ion channels","volume":"28","author":"Tang","year":"2018","journal-title":"Cell Res"},{"key":"10.1016\/j.bmc.2024.118021_b0245","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36852","article-title":"Structure of the human lipid-gated cation channel TRPC3","volume":"7","author":"Fan","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.bmc.2024.118021_b0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12035-008-8018-z","article-title":"Dendritic spine loss and synaptic alterations in Alzheimer's disease","volume":"37","author":"Knobloch","year":"2008","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.bmc.2024.118021_b0255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1326-9-51","article-title":"Models of beta-amyloid induced Tau-pathology: the long and \u201cfolded\u201d road to understand the mechanism","volume":"9","author":"Stancu","year":"2014","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bmc.2024.118021_b0260","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/mp.2016.104","article-title":"A CNS-permeable Hsp90 inhibitor rescues synaptic dysfunction and memory loss in APP-overexpressing Alzheimer's mouse model via an HSF1-mediated mechanism","volume":"22","author":"Wang","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bmc.2024.118021_b0265","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1523\/JNEUROSCI.0151-13.2014","article-title":"Hsp90 chaperone inhibitor 17-AAG attenuates Abeta-induced synaptic toxicity and memory impairment","volume":"34","author":"Chen","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2024.118021_b0270","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.118021_b0275","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2174\/1570159X15666170720095240","article-title":"Microglia and astrocytes in Alzheimer's disease: implications for therapy","volume":"16","author":"Fakhoury","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.bmc.2024.118021_b0280","doi-asserted-by":"crossref","first-page":"13116","DOI":"10.1523\/JNEUROSCI.1890-10.2010","article-title":"Transient receptor potential canonical 3 (TRPC3) mediates thrombin-induced astrocyte activation and upregulates its own expression in cortical astrocytes","volume":"30","author":"Shirakawa","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2024.118021_b0285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1750-1326-6-63","article-title":"Alzheimer's disease: synapses gone cold","volume":"6","author":"Koffie","year":"2011","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bmc.2024.118021_b0290","first-page":"1057","article-title":"Cytochrome P450-catalyzed metabolism of ezlopitant alkene (CJ-12,458), a pharmacologically active metabolite of ezlopitant: enzyme kinetics and mechanism of an alkene hydration reaction","volume":"29","author":"Obach","year":"2001","journal-title":"Drug Metab Dispos"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624004358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624004358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T09:01:26Z","timestamp":1737795686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624004358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":58,"alternative-id":["S0968089624004358"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.118021","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a potent and selective TRPC3 antagonist with neuroprotective effects","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.118021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118021"}}